Universe Pharmaceuticals's book value per share for the quarter that ended in Sep. 2025 was $99.70.
During the past 12 months, Universe Pharmaceuticals's average Book Value Per Share Growth Rate was -91.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -76.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -50.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Universe Pharmaceuticals was 82.60% per year. The lowest was -76.60% per year. And the median was 10.40% per year.
During the past 8 years, the highest P/B Ratio of Universe Pharmaceuticals was 5.45. The lowest was 0.01. And the median was 0.27.
Universe Pharmaceuticals (NAS:UPC) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Universe Pharmaceuticals Book Value per Share Related Terms
Universe Pharmaceuticals Book Value per Share Historical Data
* Premium members only.
The historical data trend for Universe Pharmaceuticals's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Universe Pharmaceuticals Book Value per Share Chart
UPC vs CPMD, SHPH, NPHC: Book Value per Share Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Universe Pharmaceuticals's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Universe Pharmaceuticals PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Universe Pharmaceuticals's PB Ratio distribution charts can be found below:
* The bar in red indicates where Universe Pharmaceuticals's PB Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Universe Pharmaceuticals (UPC) has a Book Value per Share of $99.70 as of Sep. 2025. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Universe Pharmaceuticals and its competitors.
Is Universe Pharmaceuticals' Book Value per Share too high?
Universe Pharmaceuticals' current Book Value per Share is $99.70. Overall, Universe Pharmaceuticals has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Universe Pharmaceuticals' Book Value per Share compare to CPMD and SHPH?
Universe Pharmaceuticals' Book Value per Share of $99.70 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Book Value per Share for a Drug Manufacturers company?
A good Book Value per Share depends on the Drug Manufacturers industry context. However, Book Value per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Book Value per Share mean?
A high Book Value per Share can signal that a stock is expensive relative to its fundamentals. Book value per share gives the per-share value of a company's stockholder equity. View historical data on Universe Pharmaceuticals and its competitors. Universe Pharmaceuticals's current Book Value per Share is $99.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universe Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Universe Pharmaceuticals (UPC) is currently considered Modestly Overvalued. The stock's GF Value™ is $5.20, compared to a current price of $6.21 — trading 19.4% above its estimated fair value. The current Book Value per Share is $99.70. Universe Pharmaceuticals' overall GF Score™ is 62/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Book Value per Share calculated?
Book Value per Share is calculated from a company's financial statements. For Universe Pharmaceuticals (UPC), the current Book Value per Share is $99.70 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Universe Pharmaceuticals (UPC) Overvalued in 2026?
Based on GuruFocus' analysis, Universe Pharmaceuticals stock appears to be overvalued.
The current stock price of $6.21 is trading 19.4% above its estimated GF Value™ of $5.20.
GuruFocus considers Universe Pharmaceuticals to be Modestly Overvalued.
Key valuation signals for UPC:
Book Value per Share: $99.70
GF Value™: $5.20 vs. price of $6.21 (19.4% above fair value)
No single metric tells the full story. See the UPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
62GF Score
Get the complete analysis for UPC
Book Value per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UPC has been successfully added to your 
